myTomorrows, a global health technology company connecting patients with all possible treatment options, today announced a new partnership with Pancreatic Cancer Europe, a multi-stakeholder platform that brings together experts from all over Europe with a common interest and willingness to improve care for patients with pancreatic cancer. Through the new partnership, Pancreatic Cancer Europe (PCE) will utilize myTomorrows’ vast database of ongoing clinical trials to equip patients, caregivers and healthcare professionals with up-to-date, accessible information about pre-approval treatments...